The CELA3B gene helps the pancreas make a digestive enzyme that breaks down proteins in food. If this gene does not work as expected, the enzyme may be made or activated in the wrong way, which can irritate the pancreas and raise the chance of recurrent pancreatitis, a painful inflammation of the pancreas. Many variants are harmless, while a few may affect pancreatic health. CELA3B is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or direct processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes take place, where they occur, and how strongly they run. In combination, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. To go into this subject in more detail, you can find more in the LearnHub.
Overview
CELA3BGene function
What if the gene works
The CELA3B gene helps the pancreas make a digestive enzyme. This enzyme is released into the small intestine after meals, where it helps break down proteins in food.
Risk
What if the gene does not work
Some variants in the CELA3B gene are linked to recurrent or chronic pancreatitis, with upper belly pain and, over time, digestive problems or diabetes. Effects can range from milder to more severe depending on the variant.
Treatment
What does that mean for your treatment
No CELA3B-specific treatment or management approach is currently established, and treatment choices are not routinely changed because of a pathogenic variant in the CELA3B gene. Research is exploring how CELA3B variants may contribute to pancreatitis, but this has not yet led to guideline-based drug selection.
Gene function
What if the gene works
After you eat, your pancreas releases enzymes that help break food into smaller pieces. The CELA3B gene provides instructions for one of these enzymes, called pancreatic elastase. This helps explain what the CELA3B gene does in the pancreas during everyday digestion.
In the pancreas, the CELA3B gene helps make pancreatic elastase, a digestive enzyme. This enzyme is produced in cells that prepare and package digestive juices for meals.
Your body first makes this enzyme in an inactive form. That lets the pancreas store it and release it at the right time for digestion in the small intestine.
Once activated in the small intestine, pancreatic elastase helps cut large food proteins into smaller pieces. This supports normal digestion and helps your body handle protein from meals.
Pancreatic elastase works alongside other digestive enzymes released by the pancreas. Together they help break down the protein part of food in a steady, coordinated way.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CELA3B gene can change how the enzyme folds, is processed, or how much of it is produced, which may alter its activity in pancreatic cells. Some CELA3B gene variants linked to chronic pancreatitis, especially changes affecting amino acid 90, appear to increase enzyme expression or activity rather than reduce it. Milder variants may cause small functional shifts, while more disruptive variants can have a larger effect and may be tied to earlier or persistent pancreatic inflammation.
How variants are linked to conditions
Rare pathogenic variants in the CELA3B gene are linked to chronic pancreatitis, including familial cases and recurrent pancreatitis that can begin in childhood or adulthood. The clearest, best-supported association is between the CELA3B gene and chronic pancreatitis, not a broad range of unrelated conditions. These variants are uncommon, and carrying a risk-linked change does not mean symptoms will definitely develop.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to CELA3B itself. For people with a CELA3B change linked to pancreatitis, common pancreatitis triggers such as heavy alcohol use and smoking may still matter, and a doctor or genetic counselor can help put personal risk in context.
Inheritance of CELA3B variants
In families with CELA3B-related pancreatitis, the CELA3B gene inheritance pattern is usually autosomal dominant. This means a variant in just one copy of the gene can be enough to raise the chance of disease, and a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy. Men and women can inherit and pass on the variant equally. Not everyone who inherits a CELA3B variant will develop symptoms, so inheritance affects risk rather than guaranteeing illness.
What does my CELA3B result mean for my family?
For CELA3B, some gene changes linked to pancreatitis can run in families in a dominant pattern, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. For many families, this means relatives may want to learn whether the variant is present, especially if there is a history of repeated pancreatitis. Not everyone with a CELA3B variant will have the same symptoms.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CELA3B gene, genetic testing for CELA3B gene variants reads DNA from a blood or saliva sample. A lab compares your CELA3B gene sequence with the usual reference sequence and reports whether a variant was found and how it is classified.
When should I consider getting a genetic test?
Genetic testing for the CELA3B gene may be worth considering if you or close relatives have repeated attacks of pancreas inflammation, especially when they start early or happen without a clear cause. Some changes in CELA3B are linked to inherited chronic pancreatitis, so testing can help clarify whether the condition may run in a family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape the way a person responds to medication. It studies links between genes and drugs to help explain why the same treatment may not work the same way for everyone. With many medicines, genes can affect how much effect a drug has or how the body handles it. This information can support treatment choices that are both better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CELA3B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work. Questions about side effects, trouble taking a treatment, or whether a medication fits your overall health are best discussed with your doctor.
History
CELA3B entered the medical literature through studies of pancreatic digestive enzymes, where researchers first described closely related human elastase proteins before the gene itself was clearly mapped. Early reports used older naming systems for pancreatic elastases, and scientific classifications changed as researchers learned more about the gene. From these first observations, research expanded steadily, helping separate CELA3B from similar elastase genes and clarifying its place in the human genome. More recently, interest in the CELA3B gene has grown because rare inherited variants have been linked to pancreatitis in some families, giving this previously niche gene a clearer place in clinical genetics.